Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA clears midazolam for use in children

March 21, 1997

Dermagraft-TC cleared for marketing

March 20, 1997

Tretinoin gel launched in the U.S.

March 19, 1997

Roberts' Agrylin approved by FDA

March 18, 1997

ProCyte's hair transplant wound dressing approved by FDA

March 17, 1997

FDA approves Viracept for adult and pediatric use

March 17, 1997

First approval for Zomig; antimigraine agents in development

March 14, 1997

First approval for naratriptan

March 12, 1997

Pfizer initiates clinical trial in panic disorder

March 12, 1997

Teva receives tentative approval for ketorolac tromethamine

March 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...